Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sector Update: Healthcare Stocks Steady Pre-Bell Monday

Sector Update: Healthcare Stocks Steady Pre-Bell Monday

MT newswireMT newswire2026/10/05 13:23

09:23 AM EDT, 10/05/2026 (MT Newswires) -- Healthcare stocks were steady pre-bell Monday, with the iShares Biotechnology ETF (IBB) inactive and the State Street Health Care Select Sector SPDR ETF (XLV) marginally lower. Vaxcyte (PCVX) shares were up more than 56% after the company said its experimental VAX-31 drug candidate met all pre-specified primary endpoints across age groups studied, compared with Prevnar 20 and/or Capvaxive, in a phase 3 trial of the invasive pneumococcal disease and pneumococcal pneumonia treatment. Alvotech (ALVO) has received US Food and Drug Administration approval for a supplement to the biologics license application for AVT02, marketed as Simlandi in the US, the company said. Alvotech stock was nearly 9% higher premarket. Insmed (INSM) Chief Financial Officer Sara Bonstein is stepping down, the company said. Insmed shares were down more than 2% pre-bell.

09:23 AM EDT, 10/05/2026 (MT Newswires) -- Healthcare stocks were steady pre-bell Monday, with the iShares Biotechnology ETF (IBB) inactive and the State Street Health Care Select Sector SPDR ETF (XLV) marginally lower. Vaxcyte (PCVX) shares were up more than 56% after the company said its experimental VAX-31 drug candidate met all pre-specified primary endpoints across age groups studied, compared with Prevnar 20 and/or Capvaxive, in a phase 3 trial of the invasive pneumococcal disease and pneumococcal pneumonia treatment. Alvotech (ALVO) has received US Food and Drug Administration approval for a supplement to the biologics license application for AVT02, marketed as Simlandi in the US, the company said. Alvotech stock was nearly 9% higher premarket. Insmed (INSM) Chief Financial Officer Sara Bonstein is stepping down, the company said. Insmed shares were down more than 2% pre-bell.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Arbitrage trading is still profitable, but the "easy win" era may be over! Citi warns of narrowing spread risks

The US foreign exchange trading team at Citigroup expects that although carry trade strategies may find it difficult to replicate the impressive returns of the previous period, they will still continue to offer profit opportunities for investors.

智通财经•2026/11/03 01:11

BNB falls below $700

金色财经•2026/11/03 01:03
BNB falls below $700

Continue fueling AI expenses! Oracle (ORCL.US) reportedly close to selling $10 billions in stocks at an 11% discount, priced at $116.

It is reported that Oracle is about to sell shares worth 10 billions USD at an 11% discount.

智通财经•2026/11/03 00:57